BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21894279)

  • 41. Adverse Events of Proton Pump Inhibitors: Potential Mechanisms.
    Corsonello A; Lattanzio F; Bustacchini S; Garasto S; Cozza A; Schepisi R; Lenci F; Luciani F; Maggio MG; Ticinesi A; Butto V; Tagliaferri S; Corica F
    Curr Drug Metab; 2018; 19(2):142-154. PubMed ID: 29219052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.
    Thurber KM; Otto AO; Stricker SL
    Am J Health Syst Pharm; 2023 Apr; 80(8):487-494. PubMed ID: 36629265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux].
    Bredenoord AJ; Smout AJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2548-52. PubMed ID: 19174935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxicity of long-term use of proton pump inhibitors in children.
    De Bruyne P; Ito S
    Arch Dis Child; 2018 Jan; 103(1):78-82. PubMed ID: 29237614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Gastro-esophageal reflux through gastric antisecretory drugs].
    Jian R
    Gastroenterol Clin Biol; 2009; 33(8-9):614-24. PubMed ID: 19674856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
    Vakil N
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():64-9. PubMed ID: 16042661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The interaction between proton pump inhibitors and clopidogrel and upper gastrointestinal bleeding.
    Leontiadis GI; Yuan Y; Howden CW
    Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):637-56. PubMed ID: 21944415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indications and safety of proton pump inhibitor drug use in patients with cancer.
    Triadafilopoulos G; Roorda AK; Akiyama J
    Expert Opin Drug Saf; 2013 Sep; 12(5):659-72. PubMed ID: 23647006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Side effects of proton pump inhibitors (PPIs)].
    Maffei M; Desmeules J; Cereda JM; Hadengue A
    Rev Med Suisse; 2007 Sep; 3(123):1934-6, 1938. PubMed ID: 17918487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of proton pump inhibitor exposure.
    Yang YX; Metz DC
    Gastroenterology; 2010 Oct; 139(4):1115-27. PubMed ID: 20727892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [What is the REAL long-term risk of proton pump inhibitors?].
    Ribiere S; Guillaumot MA; Barré A; Abou Ali E; Barret M; Chaussade S; Coriat R
    Presse Med; 2019 May; 48(5):503-510. PubMed ID: 30926204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PPIs and Safety Concerns - A Pending Verdict?
    Upadhyay R; Chhabra YK; Gupta A; Datley AY
    J Assoc Physicians India; 2021 Apr; 69(4):11-12. PubMed ID: 34470193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
    Johnson DA; Levy BH
    Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lessons from two cases of anaphylaxis to proton pump inhibitors.
    Choi SW; Han JM; Bae YJ; Lee YS; Cho YS; Moon HB; Kim TB
    J Clin Pharm Ther; 2012 Oct; 37(5):614-6. PubMed ID: 22642701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of proton pump-inhibiting drugs on mineral metabolism.
    Insogna KL
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S2-4. PubMed ID: 19262542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proton Pump Inhibitors: The Good, Bad, and Ugly.
    Schnoll-Sussman F; Niec R; Katz PO
    Gastrointest Endosc Clin N Am; 2020 Apr; 30(2):239-251. PubMed ID: 32146944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proton pump-inhibiting drugs, calcium homeostasis, and bone health.
    Wright MJ; Proctor DD; Insogna KL; Kerstetter JE
    Nutr Rev; 2008 Feb; 66(2):103-8. PubMed ID: 18254877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Adverse effects of long-term proton-pump inhibitor therapy on adults].
    Igaz I; Simonyi G; Balogh S; Szathmári M
    Orv Hetil; 2018 May; 159(19):735-740. PubMed ID: 29730946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards.
    van Vliet EP; Otten HJ; Rudolphus A; Knoester PD; Hoogsteden HC; Kuipers EJ; Siersema PD
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):608-12. PubMed ID: 18679061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.